1
|
Murakami I, Fujii T, Dan K, Saito M, Ohno
A, Iwata T and Aoki D: Methylation of human papillomavirus-52 and
−58 is a candidate biomarker in cervical neoplasia. J Clin Virol.
58:149–154. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Marongiu L, Godi A, Parry JV and Beddows
S: Human Papillomavirus 16, 18, 31 and 45 viral load, integration
and methylation status stratified by cervical disease stage. BMC
Cancer. 14:3842014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Schiffman M, Castle PE, Jeronimo J,
Rodriguez AC and Wacholder S: Human papillomavirus and cervical
cancer. Lancet. 370:890–907. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Clarke MA, Wentzensen N, Mirabello L,
Ghosh A, Wacholder S, Harari A, Lorincz A, Schiffman M and Burk RD:
Human papillomavirus DNA methylation as a potential biomarker for
cervical cancer. Cancer Epidemiol Biomarkers Prev. 21:2125–2137.
2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kalantari M, Osann K, Calleja-Macias IE,
Kim S, Yan B, Jordan S, Chase DM, Tewari KS and Bernard HU:
Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1
genes and the cellular DAPK gene: Considerations for use as
biomarkers of the progression of cervical neoplasia. Virology.
448:314–321. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Whiteside MA, Siegel EM and Unger ER:
Human papillomavirus and molecular considerations for cancer risk.
Cancer. 113:(10 Suppl). S2981–S2994. 2008. View Article : Google Scholar
|
7
|
Kim SS, Suh DS, Kim KH, Yoon MS and Choi
KU: Clinicopathological significance of atypical glandular cells on
Pap smear. Obstet Gynecol Sci. 56:76–83. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhou J, Tomashefski JF Jr, Sawady J,
Ferrer H and Khiyami A: The diagnostic value of the ThinPrep pap
test in endometrial carcinoma: A prospective study with
histological follow-up. Diagn Cytopathol. 41:408–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
9
|
De Strooper LM, van Zummeren M,
Steenbergen RD, Bleeker MC, Hesselink AT, Wisman GB, Snijders PJ,
Heideman DA and Meijer CJ: CADM1, MAL and miR124-2 methylation
analysis in cervical scrapes to detect cervical and endometrial
cancer. J Clin Pathol. 67:1067–1071. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Arbyn M, Ronco G, Anttila A, Meijer CJ,
Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R
and Peto J: Evidence regarding human papillomavirus testing in
secondary prevention of cervical cancer. Vaccine. 30:(Suppl 5).
F88–F99. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Bryant D, Tristram A, Liloglou T, Hibbitts
S, Fiander A and Powell N: Quantitative measurement of human
papillomavirus type 16 L1/L2 DNA methylation correlates with
cervical disease grade. J Clin Virol. 59:24–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Baylin SB and Herman JG: DNA
hypermethylation in tumorigenesis: Epigenetics joins genetics.
Trends Genet. 16:168–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
13
|
Shivapurkar N, Sherman ME, Stastny V,
Echebiri C, Rader JS, Nayar R, Bonfiglio TA, Gazdar AF and Wang SS:
Evaluation of candidate methylation markers to detect cervical
neoplasia. Gynecol Oncol. 107:549–553. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kalantari M, Villa LL, Calleja-Macias IE
and Bernard HU: Human papillomavirus-16 and −18 in penile
carcinomas: DNA methylation, chromosomal recombination and genomic
variation. Int J Cancer. 123:1832–1840. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Wentzensen N, Sun C, Ghosh A, Kinney W,
Mirabello L, Wacholder S, Shaber R, LaMere B, Clarke M, Lorincz AT,
et al: Methylation of HPV18, HPV31, and HPV45 genomes and cervical
intraepithelial neoplasia grade III. J Natl Cancer Inst.
104:1738–1749. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Sun Z, Lu Z, Liu J, Wang G, Zhou W, Yang
L, Liu C, Wang B and Ruan Q: Genetic variations of E6 and long
control region of human papillomavirus type 16 from patients with
cervical lesion in Liaoning, China. BMC Cancer. 13:4592013.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Verma I, Jain V and Kaur T: Application of
bethesda system for cervical cytology in unhealthy cervix. J Clin
Diagn Res. 8:OC26–OC30. 2014.PubMed/NCBI
|
18
|
Li LC and Dahiya R: MethPrimer: Designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Xi LF, Jiang M, Shen Z, Hulbert A, Zhou
XH, Lin YY, Kiviat NB and Koutsky LA: Inverse association between
methylation of human papillomavirus type 16 DNA and risk of
cervical intraepithelial neoplasia grades II or III. PLoS One.
6:e238972011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhu WG, Srinivasan K, Dai Z, Duan W,
Druhan LJ, Ding H, Yee L, Villalona-Calero MA, Plass C and Otterson
GA: Methylation of adjacent CpG sites affects Sp1/Sp3 binding and
activity in the p21 (Cip1) promoter. Mol Cell Biol. 23:4056–4065.
2003. View Article : Google Scholar : PubMed/NCBI
|
21
|
Hong D, Ye F, Lu W, Hu Y, Wan X, Chen Y
and Xie X: Methylation status of the long control region of HPV 16
in clinical cervical specimens. Mol Med Rep. 1:555–560.
2008.PubMed/NCBI
|
22
|
Bryant D, Onions T, Raybould R, Jones S,
Tristram A, Hibbitts S, Fiander A and Powell N: Increased
methylation of human papillomavirus type 16 DNA correlates with
viral integration in Vulval Intraepithelial Neoplasia. J Clin
Virol. 61:393–399. 2014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Ding DC, Chiang MH, Lai HC, Hsiung CA,
Hsieh CY and Chu TY: Methylation of the long control region of
HPV16 is related to the severity of cervical neoplasia. Eur J
Obstet Gynecol Reprod Biol. 147:215–220. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Doerfler W, Remus R, Müller K, Heller H,
Hohlweg U and Schubbert R: The fate of foreign DNA in mammalian
cells and organisms. Dev Biol (Basel). 106:89–97; discussion
143–160. 2001.PubMed/NCBI
|
25
|
Daniel B, Mukherjee G, Seshadri L,
Vallikad E and Krishna S: Changes in the physical state and
expression of human papillomavirus type 16 in the progression of
cervical intraepithelial neoplasia lesions analysed by PCR. J Gen
Virol. 76:2589–2593. 1995. View Article : Google Scholar : PubMed/NCBI
|
26
|
Daniel B, Rangarajan A, Mukherjee G,
Vallikad E and Krishna S: The link between integration and
expression of human papillomavirus type 16 genomes and cellular
changes in the evolution of cervical intraepithelial neoplastic
lesions. J Gen Virol. 78:1095–1101. 1997. View Article : Google Scholar : PubMed/NCBI
|
27
|
Schwarz E, Freese UK, Gissmann L, Mayer W,
Roggenbuck B, Stremlau A and zur Hausen H: Structure and
transcription of human papillomavirus sequences in cervical
carcinoma cells. Nature. 314:111–114. 1985. View Article : Google Scholar : PubMed/NCBI
|
28
|
Vinokurova S, Wentzensen N, Kraus I, Klaes
R, Driesch C, Melsheimer P, Kisseljov F, Dürst M, Schneider A and
von Knebel Doeberitz M: Type-dependent integration frequency of
human papillomavirus genomes in cervical lesions. Cancer Res.
68:307–313. 2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Dutta S, Chakraborty C, Dutta AK, Mandal
RK, Roychoudhury S, Basu P and Panda C: Physical and methylation
status of human papillomavirus 16 in asymptomatic cervical
infections changes with malignant transformation. J Clin Pathol.
68:206–211. 2015. View Article : Google Scholar : PubMed/NCBI
|
30
|
Qiu C, Zhi Y, Shen Y, Gong J, Li Y and Li
X: High-resolution melting analysis of HPV-16L1 gene methylation: A
promising method for prognosing cervical cancer. Clin Biochem.
48:855–859. 2015. View Article : Google Scholar : PubMed/NCBI
|
31
|
Bird A: DNA methylation patterns and
epigenetic memory. Genes Dev. 16:6–21. 2002. View Article : Google Scholar : PubMed/NCBI
|
32
|
Fuks F: DNA methylation and histone
modifications: Teaming up to silence genes. Curr Opin Genet Dev.
15:490–495. 2005. View Article : Google Scholar : PubMed/NCBI
|
33
|
Mino A, Onoda N, Yashiro M, Aya M,
Fujiwara I, Kubo N, Sawada T, Ohira M, Kato Y and Hirakawa K:
Frequent p16 CpG island hypermethylation in primary remnant gastric
cancer suggesting an independent carcinogenic pathway. Oncol Rep.
15:615–620. 2006.PubMed/NCBI
|
34
|
Münger K, Baldwin A, Edwards KM, Hayakawa
H, Nguyen CL, Owens M, Grace M and Huh K: Mechanisms of human
papillomavirus-induced oncogenesis. J Virol. 78:11451–11460. 2004.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Yang HJ: Aberrant DNA methylation in
cervical carcinogenesis. Chin J Cancer. 32:42–48. 2013. View Article : Google Scholar : PubMed/NCBI
|
36
|
Tan SH, Leong LE, Walker PA and Bernard
HU: The human papillomavirus type 16 E2 transcription factor binds
with low cooperativity to two flanking sites and represses the E6
promoter through displacement of Sp1 and TFIID. J Virol.
68:6411–6420. 1994.PubMed/NCBI
|
37
|
Kalantari M, Calleja-Macias IE, Tewari D,
Hagmar B, Lie K, Barrera-Saldana HA, Wiley DJ and Bernard HU:
Conserved methylation patterns of human papillomavirus type 16 DNA
in asymptomatic infection and cervical neoplasia. J Virol.
78:12762–12772. 2004. View Article : Google Scholar : PubMed/NCBI
|
38
|
Rajeevan MS, Swan DC, Nisenbaum R, Lee DR,
Vernon SD, Ruffin MT, Horowitz IR, Flowers LC, Kmak D, Tadros T, et
al: Epidemiologic and viral factors associated with cervical
neoplasia in HPV-16-positive women. Int J Cancer. 115:114–120.
2005. View Article : Google Scholar : PubMed/NCBI
|
39
|
Mirabello L, Schiffman M, Ghosh A,
Rodriguez AC, Vasiljevic N, Wentzensen N, Herrero R, Hildesheim A,
Wacholder S, Scibior-Bentkowska D, et al: Elevated methylation of
HPV16 DNA is associated with the development of high grade cervical
intraepithelial neoplasia. Int J Cancer. 132:1412–1422. 2013.
View Article : Google Scholar : PubMed/NCBI
|